1-Boc-3-Azetidinone CAS 398489-26-4 Baricitinib Intermediate Purity >98.0% (GC) Factory

Short Description:

Chemical Name: 1-Boc-3-Azetidinone 

CAS: 398489-26-4

Purity: >98.0% (GC) Assay: >98.0% (QNMR)

Appearance: Light Yellow Solid

Intermediate of Baricitinib (CAS: 1187594-09-7) 

Contact: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

398489-26-4 - Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of 1-Boc-3-Azetidinone (CAS: 398489-26-4) with high and stable quality control, an important intermediate of Baricitinib (CAS: 1187594-09-7).
Ruifu Chemical has been supplying pharmaceutical intermediates and APIs more than 15 years. Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available.
Purchase 1-Boc-3-Azetidinone and Baricitinib intermediates, Please contact us by e-mail: alvin@ruifuchem.com for quotation requests. Please provide quantity, purity, and any other specific requirements. 

Intermediates of Baricitinib (CAS: 1187594-09-7):

398489-26-4 - Chemical Properties:

Chemical Name 1-Boc-3-Azetidinone 
Synonyms 1-(tert-Butoxycarbonyl)-3-Azetidinone; tert-Butyl 3-Oxoazetidine-1-Carboxylate; 3-Oxoazetidine-1-Carboxylic Acid tert-Butyl Ester; 1-Boc-Azetidin-3-One; 1-N-Boc-3-Azetidinone; 3-Oxoazetidine, N-Boc Protected
Stock Status In Stock, Commercial Production  
CAS Number 398489-26-4
Molecular Formula C8H13NO3
Molecular Weight 171.20 g/mol
Melting Point 49.0~52.0℃ 
Density 1.174±0.06 g/cm3 
Store Under Inert Gas Store Under Inert Gas
Sensitive Moisture Sensitive 
Storage Temp.  Store at 2~8℃ 
COA & MSDS Available
Origin of Product    Shanghai, China
Shelf Life 24 Months From Manufacture Date if Stored Properly
Product Categories
Pharmaceutical Intermediates
Brand Ruifu Chemical

398489-26-4 - Specifications:

Items Specifications  Results
Appearance Light Yellow Solid  Light Yellow Solid 
400 MHz 1H NMR Spectrum Conforms to Structure Conforms 
Melting Point 49.0~52.0℃ 49.3~51.7℃
Water by Karl Fischer  <0.50% 0.05%
Residue on Ignition <0.20% 0.12%
Purity / Analysis Method >98.0% (GC Area)  99.7%
Largest Unknown Impurity <1.00% <1.00%
Assay / Analysis Method  >98.0% (QNMR, w/w%)  98.3%
Conclusion The product has been tested and complies with the given specifications
Usage Intermediate of Baricitinib (CAS: 1187594-09-7)
Note: 1, Values of the results shown are based upon analysis of samples taken from this batch randomly.
          2, Observed mass shouId be within 0.10% of expected mass. 

398489-26-4 - Package/Storage/Shipping:

Package: Fluorinated Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry (2~8℃), well-ventilated warehouse away from incompatible substances. Keep away from sunshine; avoid fire and heat sources; avoid moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery. 

398489-26-4 - Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

398489-26-4 - FAQ:

How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.

Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.

Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory AuditFactory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

TransportationBy Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom SynthesisCan provide custom synthesis services to best fit your research needs.

Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

398489-26-4 - Risk and Safety:

Risk Codes R22 - Harmful if swallowed
R37/38 - Irritating to respiratory system and skin.
R41 - Risk of serious damage to eyes
Safety Description
S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S39 - Wear eye / face protection.
UN IDs UN 3335
WGK Germany 3
HS Code 2933990099
Hazard Class IRRITANT

398489-26-4 - Application:

1-Boc-3-Azetidinone (CAS: 398489-26-4), is a unique and versatile synthetic organic compound that has been used in a wide range of scientific research applications. It is a versatile building block for the synthesis of complex molecules and it has been used in the synthesis of a variety of pharmaceuticals, including antibiotics, antivirals, and anti-cancer agents.
1-Boc-3-Azetidinone is used as a pharmaceutical intermediate, intermediate of Baricitinib (CAS: 1187594-09-7). Baricitinib (trade name Olumiant) is a drug for the treatment of rheumatoid arthritis (RA), being developed by Incyte and Eli Lilly.It acts as an inhibitor of janus kinase (JAK), blocking the subtypes JAK1 and JAK2. The drug is approved in Europe. Patients with intolerance to one or more anti-rheumatic drugs can be treated with Baricitinib. Baricitinib can be treated as a single agent or combined with a combined treatment of methotrexate in therapy.

  • Write your message here and send it to us